Lazard Asset Management
CLPT icon

Lazard Asset Management’s ClearPoint Neuro CLPT Stock Holding History

Lazard Asset Management’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,888
Closed -$22K – 1899
2025
Q2 		$22K Sell
1,888
-25,856
-93% -$325K ﹤0.01% 2112
2025
Q1 		$329K Buy
27,744
+4,638
+20% +$72.1K ﹤0.01% 1515
2024
Q4 		$355K Buy
23,106
+9,433
+69% +$122K ﹤0.01% 1457
2024
Q3 		$153K Buy
+13,673
New +$131K ﹤0.01% 1669

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BCM
Boone Capital Management Atlanta, Georgia $326M AUM 86.31% 1-Year Est. Return

Lazard Asset Management's CLPT Position: Q3 2025 in Review

Lazard Asset Management sold out of ClearPoint Neuro (CLPT) in Q3 2025, closing a stake of 1,888 shares — an estimated $22K sold.

Lazard Asset Management first reported a position in CLPT in Q3 2024 and held it in 4 quarters. The position peaked at $355K in Q4 2024. 107 funds tracked by Wall St. Rank hold CLPT as of Q3 2025.

  • Lazard Asset Management reported no remaining ClearPoint Neuro position as of Q3 2025 after selling out during the quarter.
  • Lazard Asset Management sold 1,888 ClearPoint Neuro shares in Q3 2025, an estimated $22K.
  • Lazard Asset Management first reported a position in ClearPoint Neuro in Q3 2024 and held it in 4 quarters.
  • Lazard Asset Management's ClearPoint Neuro position peaked at $355K in Q4 2024.
  • 107 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q3 2025.

Based on Lazard Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.